Cargando…
ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma
BACKGROUND: Cholangiocarcinoma (CHOL) is the second most common primary hepatic malignant tumor, following hepatocellular carcinoma (HCC). CHOL is highly aggressive and heterogeneous resulting in poor prognosis. The diagnosis and prognosis of CHOL has not improved in the past decade. Acyl-CoA synthe...
Autores principales: | Liu, Shuochen, Fan, Shilong, Wang, Yirui, Chen, Ruixiang, Wang, Ziyi, Zhang, Yaodong, Jiang, Wangjie, Chen, Yananlan, Xu, Xiao, Yu, Yue, Li, Changxian, Li, Xiangcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186676/ https://www.ncbi.nlm.nih.gov/pubmed/37193981 http://dx.doi.org/10.1186/s12885-023-10903-5 |
Ejemplares similares
-
NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1
por: Shan, Jijun, et al.
Publicado: (2023) -
Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation
por: Chen, Yananlan, et al.
Publicado: (2023) -
ROBO1 p.E280* Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal
por: Zhou, Tao, et al.
Publicado: (2022) -
Development and external validation of a nomogram for predicting the effect of tumor size on survival of patients with perihilar cholangiocarcinoma
por: Zhang, Yaodong, et al.
Publicado: (2020) -
The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers
por: Zhang, Yaodong, et al.
Publicado: (2022)